home truths, page-40

Surges,

Again some quality points. Thanks. Yeah it crossed my mind that the they may have their hands tied, and given what you said about their past in reporting, that may in fact be a reasonable explanation. I hope so. Unfortunately only about a third of listed companies actually make money so being a biotech Obj has to be particularly careful when dealing with big players like 3M. Having dealt with several listed small caps, I have to say the honest side of business is generally a spectator. Having being in senior management for a long time you would have seen all sorts of agendas, so I guess unless we are physically in the office, we are reliant upon communication from the company.

My issue is in regards to their disclosure about testing. I dont believe this is a issue that would be masked by the big players, so I am interested in the motives by OBJ, and why yay or nay hasnt been advised.

If that was cleared up or made transparent, I would be happy.